HB 1416Oklahoma
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
Passed House
Apr 1, 2025: Second Reading referred to Health and Human Services Committee then to Appropriations Committee